Xencor Inc
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
XNCR$39.39+2.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity
(in thousands, except share data)
| Common Stock · AdditionalPaidin-Capital · AccumulatedOtherComprehensiveIncome (Loss) · AccumulatedDeficit · Non-Controlling Interest · TotalStockholders’Equity | |||||||
|---|---|---|---|---|---|---|---|
| Stockholders’ Equity · Shares · Amount | |||||||
| Balance, December 31, 2021 | 59,355,558 | $595 | $1,017,523 | $(1,510) | $(283,104) | $— | $733,504 |
| Issuance of common stock upon exercise of stock awards | 195,485 | 2 | 3,608 | — | — | — | 3,610 |
| Issuance of common stock under the Employee Stock Purchase Plan | 105,597 | 1 | 2,091 | — | — | — | 2,092 |
| Issuance of restricted stock units | 341,073 | 3 | (3) | — | — | — | — |
| Comprehensive loss | — | — | — | (5,442) | (55,181) | — | (60,623) |
| Stock-based compensation | — | — | 48,913 | — | — | — | 48,913 |
| Balance, December 31, 2022 | 59,997,713 | 601 | 1,072,132 | (6,952) | (338,285) | — | 727,496 |
| Issuance of common stock upon exercise of stock awards | 344,383 | 3 | 3,409 | — | — | — | 3,412 |
| Issuance of common stock under the Employee Stock Purchase Plan | 98,029 | 1 | 1,976 | — | — | — | 1,977 |
| Issuance of restricted stock units | 558,066 | 6 | (6) | — | — | — | — |
| Contribution from non-controlling interest owners | — | — | — | — | — | 500 | 500 |
| Comprehensive income (loss) | — | — | — | 8,243 | (133,133) | (163) | (125,053) |
| Stock-based compensation | — | — | 53,755 | — | — | — | 53,755 |
| Balance, December 31, 2023 | 60,998,191 | 611 | 1,131,266 | 1,291 | (471,418) | 337 | 662,087 |
| Sale of common stock and pre-funded warrants, net of issuance cost | 8,093,712 | 81 | 189,098 | — | — | — | 189,179 |
| Issuance of common stock upon exercise of stock awards | 458,857 | 4 | 6,309 | — | — | — | 6,313 |
| Issuance of common stock under the Employee Stock Purchase Plan | 96,234 | 1 | 1,659 | — | — | — | 1,660 |
| Issuance of restricted stock units | 609,114 | 6 | (6) | — | — | — | — |
| Comprehensive loss | — | — | — | (1,954) | (232,618) | (3,922) | (238,494) |
| Stock-based compensation | — | — | 53,281 | — | — | — | 53,281 |
| Balance, December 31, 2024 | 70,256,108 | $703 | $1,381,607 | $(663) | $(704,036) | $(3,585) | $674,026 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.